Skip to main content
. 2014 Jan 20;2014(1):CD010927. doi: 10.1002/14651858.CD010927

4.11. Analysis.

4.11

Comparison 4 Dihydroartemisinin‐piperaquine versus Artemether‐lumefantrine, Outcome 11 Other adverse events: Gastrointestinal.